Tomonori Aono
Overview
Explore the profile of Tomonori Aono including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watanabe K, Fukui A, Aono T, Aita S, Matsui M
Eur Heart J Case Rep
. 2025 Mar;
9(3):ytaf097.
PMID: 40061111
Background: Post-infarction scar-related ventricular tachycardia (VT) originating from the right ventricular (RV) free wall in patients with RV infarction is rare. Case Summary: A 75-year-old Asian male, with a history...
2.
Saito Y, Otaki Y, Watanabe T, Tachibana S, Sato J, Kobayashi Y, et al.
J Mol Cell Cardiol Plus
. 2025 Jan;
2():100018.
PMID: 39802494
Background: Septic cardiomyopathy is a common complication of septic shock and organ dysfunction. ITCH is a HECT (homologous to the E6-AP carboxyl-terminus)-type ubiquitin E3 ligase that plays a critical role...
3.
Hashimoto N, Arimoto T, Koyama K, Kutsuzawa D, Watanabe K, Aita S, et al.
J Cardiovasc Electrophysiol
. 2023 Sep;
34(10):2055-2064.
PMID: 37681313
Introduction: Atrial fibrillation (AF) is a risk factor for reduced cerebral blood flow (CBF) and cognitive dysfunction, even in stroke-free patients. We aimed to test the hypothesis that CBF and...
4.
Kobayashi Y, Otaki Y, Watanabe T, Tachibana S, Sato J, Saito Y, et al.
JACC Asia
. 2023 Jul;
3(3):457-471.
PMID: 37396418
Background: Despite a reduction in the rate of thrombotic events, ischemic heart disease (IHD) remains a key medical problem associated with high major bleeding and mortality in Asian patients with...
5.
Otaki Y, Watanabe T, Shimizu M, Tachibana S, Sato J, Kobayashi Y, et al.
ESC Heart Fail
. 2023 Jun;
10(4):2458-2468.
PMID: 37264723
Aims: Despite advances in heart failure (HF) treatment, HF with preserved ejection fraction (HFpEF) remains a health problem with a high mortality rate. HFpEF is composed of diverse phenogroups, of...
6.
Otaki Y, Shimizu M, Watanabe T, Tachibana S, Sato J, Kobayashi Y, et al.
Circ J
. 2023 Mar;
87(8):1120-1129.
PMID: 36948614
Background: Heart failure (HF) is an increasing health problem associated with a high mortality rate. Growth differentiation factor (GDF) 15, a stress response cytokine belonging to the transforming growth factor-β...
7.
Watanabe K, Arimoto T, Watanabe T, Otaki Y, Murase T, Nakamura T, et al.
J Cardiol
. 2023 Feb;
81(5):469-475.
PMID: 36822544
Background: Xanthine oxidoreductase (XOR) is a rate-limiting enzyme for uric acid (UA) production and plays an important role in generating reactive oxygen species (ROS). Overproduction of ROS is reported to...
8.
Otaki Y, Watanabe T, Shimizu M, Tachibana S, Sato J, Kobayashi Y, et al.
Sci Rep
. 2022 Oct;
12(1):16673.
PMID: 36198898
Malnutrition, glomerular damage (GD), and renal tubular damage (RTD) are common morbidities associated with poor clinical outcomes in heart failure (HF) patients. However, the association between malnutrition and renal dysfunction...
9.
Takahashi T, Watanabe T, Aono T, Otaki Y, Wanezaki M, Nishiyama S, et al.
J Atheroscler Thromb
. 2022 Sep;
30(7):786-794.
PMID: 36123047
Aims: Renal dysfunction is an independent predictor of adverse outcomes in patients with coronary artery disease (CAD). However, the prognostic impact of mid-term changes in renal dysfunction status remains unclear....
10.
Otaki Y, Shimizu M, Watanabe T, Tachibana S, Sato J, Kobayashi Y, et al.
Heart Vessels
. 2022 May;
37(11):1829-1840.
PMID: 35596031
Despite advances in medicine, heart failure with preserved ejection fraction (HFpEF) remains an increasing health concern associated with a high mortality rate. Research has shown sex-based differences in the clinical...